Obesity, Visceral Fat, and NAFLD: Querying
the Role of Adipokines in the Progression of
Nonalcoholic Fatty Liver Disease
Table 2
(a) International Diabetes Foundation; metabolic syndrome worldwide definition [15, 24]. (b) Country-/ethnicity-specific values for waist circumference [15, 24].
(a)
Central obesity
Waist circumference*-ethnicity specific
Plus any two of the following
Raised triglycerides
≥1.7 mmol/L (150 mg/dL) Or speccfic treatment for this lipid abnormality
Reduced HDL-cholesterol
<1.03 mmol/L (40 mg/dL) in males <1.29 mmol/L (50 mg/dL) in females Or specific treatment for this lipid abnormality
Raised blood pressure
Systolic: ≥130 mmHg or diastolic: ≥85 mmHg Or treatment for previously diagnosed hypertension
Raised plasma glucose
Fasting plasma glucose ≥5.6 mmol/L (100 mg/dL) Or previously diagnosed type 2 diabetes If above 5.6 mmol or 100 mg/dL An oral glucose tolerance test is strongly recommended but is not necessary to define the presence of the syndrome
(b)
Country/ethnic group
Waist circumference (cm) (as measure of central obesity)
